Pre-market · Regular session opens 9:30 AM ET
Last update: Jul 20, 2026, 5:23 PM ET
Thermo Fisher Scientific Inc.
$526.23 1.17% today
Pre-market

Why Thermo Fisher Scientific Inc. (TMO) stock moved

Updated Jul 21, 2026

Thermo Fisher Scientific Inc. (TMO) shares fell 1.2% to $526.23 as of July 21, 2026, a modest decline from the prior close of $532.48. BestStocks flagged the session as a major change for TMO. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for TMO, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

TMO fell 1.2% to $526.23

TMO fell 1.2% in its latest session, moving from $532.48 to $526.23.

ActivityWeak confidence
Rel. volume
0.5×
Below Avg
Vs peers
No comparable peers
Market cap
$195.6B
New York Stock Exchange
Analyst target
$585
+11.2% vs price
Price chart
Jul 21
Not enough price data.
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Thermo Fisher Scientific Inc. investors

For Thermo Fisher Scientific Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Thermo Fisher Scientific Inc. (TMO) moved +1.48% from $535.29 to $543.19 on 2026-07-16; Thermo Fisher Scientific Inc. (TMO) moved +0.23% from $534.07 to $535.29 on 2026-07-15. Weighing against that: Negative session, down 1.2%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $585.18, implying +11.2% upside from $526.23. Over the past 90 days analysts logged 0 upgrades and 1 downgrade. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 2 days out, the next report is the most likely near-term test of the move.

TMO price reaction

TMO last traded at $526.23, down $6.25 (-1.17%) from the previous close of $532.48. The session traded on 0.5× average volume (below avg), so participation was unremarkable.

Bullish and bearish analyst opinions on Thermo Fisher Scientific Inc. (TMO)

The consensus analyst price target on Thermo Fisher Scientific Inc. (TMO) is $585.18, 11.2% above the recent $526.23. Over the past 90 days analysts logged 0 upgrades, 4 maintains, and 1 downgrade. Here is how the bullish and bearish cases on TMO line up.

The bullish case

  • Wall Street's consensus price target of $585.18 implies +11.2% upside from $526.23.
  • The Street's most bullish target is $683.00 (+29.8%).
  • Thermo Fisher Scientific Inc. (TMO) moved +1.48% from $535.29 to $543.19 on 2026-07-16.

The bearish case

  • The most bearish analyst target is $490.00 (-6.9%).
  • 1 analyst downgrade in the past 90 days, most recently HSBC to Hold (2026-06-03).
  • Negative session, down 1.2%.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $585+11.2%
= 4 maintains1 downgrades
Evercore ISI Group maintained Outperform · 2026-07-06
SEC filings watch
No recent filings
Peer context
TMO-1.2%

Previous notable changes for TMO

Activity2026-07-16
Thermo Fisher Scientific Inc. (TMO) moved +1.48% from $535.29 to $543.19 on 2026-07-16. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move appears to be part of a sector-wide rally: five healthcare peers (AMGN +4.60%, MRK +5.67%, ABBV +3.93%, PFE +3.67%) moved in the same direction on the same day. Volume was near its 5-day average.
Activity2026-07-15
Thermo Fisher Scientific Inc. (TMO) moved +0.23% from $534.07 to $535.29 on 2026-07-15. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move appears to be driven by technical factors: TMO reached a new 30-day high with volume 1.3x the 5-day average.
Activity2026-07-14
Thermo Fisher Scientific Inc. (TMO) moved +1.05% from $528.51 to $534.07 on 2026-07-14, reaching a new 30-day high. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.5x the 5-day average, modestly elevated.
Activity2026-07-13
Thermo Fisher Scientific Inc. (TMO) moved +0.28% from $527.05 to $528.51 on 2026-07-13, reaching a new 30-day high. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
Upcoming catalysts & outlook
Next earnings
2026-07-23 (est.)
in 2 days
Thesis shift
Neutral / Mixed
bullish signal
Risk level
Low
from change events

Frequently asked questions about TMO

Why did Thermo Fisher Scientific Inc. (TMO) stock move?

TMO fell 1.2% to $526.23. No single company-specific catalyst was confirmed during the move window, and it looks technical.

How much did TMO stock fall?

TMO lost 1.17% ($6.25) versus the prior close of $532.48, last trading at $526.23 on 0.5× average volume.

When is Thermo Fisher Scientific Inc.'s next earnings date?

TMO's next earnings report is estimated for 2026-07-23 — about 2 days away.

What is the analyst price target for TMO?

The consensus analyst price target for TMO is $585.18, about 11.2% above the current $526.23. Over the past 90 days, analysts recorded 0 upgrades, 4 maintains, and 1 downgrade.

How BestStocks tracks TMO

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared TMO-specific materiality thresholds, triggering an evidence check. It draws on 13 tracked change events for TMO, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.